Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Biogen (GB:0R1B)
LSE:0R1B
Holding GB:0R1B?
Track your performance easily
See the Price Targets and Ratings of:
0R1B Analyst Ratings
Moderate Buy
11 Buy
12 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
0R1B Stock 12 Month Forecast
Average Price Target
$225.37
▲(49.89% Upside)
| Highest Price Target$300.00 | Average Price Target$225.37 | Lowest Price Target$138.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Truist Financial
Reiterated
01/13/25
Piper Sandler
Reiterated
01/13/25
Wells Fargo
Reiterated
01/12/25
RBC Capital
Reiterated
01/07/25
BMO Capital
Downgraded
12/20/24
Leerink Partners
Reiterated
12/19/24
Stifel Nicolaus
Downgraded
12/16/24
Bank of America Securities
Initiated
12/10/24
Jefferies
Downgraded
12/09/24
Morgan Stanley
Reiterated
12/05/24
Mizuho Securities
$251→$207
Buy
37.67%
Upside
Reiterated
11/21/24
Biogen price target lowered to $207 from $251 at MizuhoBiogen price target lowered to $207 from $251 at Mizuho
Raymond James
―
Hold
―
Reiterated
11/14/24
Raymond James sees EU Leqembi uptake as more modest for Biogen than in U.S.Raymond James sees EU Leqembi uptake as more modest for Biogen than in U.S.
Wolfe Research
―
Hold
―
Initiated
11/14/24
Biogen initiated with a Peer Perform at Wolfe ResearchBiogen initiated with a Peer Perform at Wolfe Research
Best Analysts Covering Biogen
Which Analyst Should I Follow If I Want to Buy GB:0R1B and Sell After:
1 Month
xxx
Success Rate
15/33 ratings generated profit
Average Return
<+0.01%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 45.45% of your transactions generating a profit, with an average return of <+0.01% per trade.
3 Months
xxx
Success Rate
19/39 ratings generated profit
Average Return
-1.11%
reiterated a xxx
rating 27 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 48.72% of your transactions generating a profit, with an average return of -1.11% per trade.
1 Year
Success Rate
12/39 ratings generated profit
Average Return
-6.95%
reiterated a buy rating 27 days ago
Copying Marc Goodman's trades and holding each position for 1 Year would result in 30.77% of your transactions generating a profit, with an average return of -6.95% per trade.
2 Years
xxx
Success Rate
10/39 ratings generated profit
Average Return
-19.21%
reiterated a xxx
rating 27 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 25.64% of your transactions generating a profit, with an average return of -19.21% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
0R1B Analyst Recommendation Trends
Rating
Sep 24
Oct 24
Nov 24
Dec 24
Jan 25
Strong Buy
5
14
17
16
7
Buy
30
29
17
9
3
Hold
11
18
21
22
14
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
46
61
55
47
24
Each month's total comprises the sum of three months' worth of ratings.
0R1B Financial Forecast
0R1B Stock Forecast FAQ
What is GB:0R1B’s average 12-month price target, according to analysts?
Based on analyst ratings, Biogen’s 12-month average price target is $225.37.
What is GB:0R1B’s upside potential, based on the analysts’ average price target?
Biogen has 49.89% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Biogen a Buy, Sell or Hold?
Biogen has a consensus rating of Moderate Buy, which is based on 11 buy ratings, 12 hold ratings and 0 sell ratings.
What is Biogen’s share price target?
The average share price target for Biogen is $225.37. This is based on 23 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is $300.00 ,and the lowest forecast is $138.00. The average share price target represents 49.89% Increase from the current price of $150.36.
The highest analyst share price target is $300.00 ,and the lowest forecast is $138.00. The average share price target represents 49.89% Increase from the current price of $150.36.
What do analysts say about Biogen?
Biogen’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 23 Wall Streets Analysts.
How can I buy shares of Biogen?
To buy shares of GB:0R1B, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.